Department of Urology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, China.
Front Immunol. 2024 Jun 6;15:1298087. doi: 10.3389/fimmu.2024.1298087. eCollection 2024.
Upper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BLCA) both originate from uroepithelial tissue, sharing remarkably similar clinical manifestations and therapeutic modalities. However, emerging evidence suggests that identical treatment regimens may lead to less favorable outcomes in UTUC compared to BLCA. Therefore, it is imperative to explore molecular processes of UTUC and identify biological differences between UTUC and BLCA.
In this study, we performed a comprehensive analysis using single-cell RNA sequencing (scRNA-seq) on three UTUC cases and four normal ureteral tissues. These data were combined with publicly available datasets from previous BLCA studies and RNA sequencing (RNA-seq) data for both cancer types. This pooled analysis allowed us to delineate the transcriptional differences among distinct cell subsets within the microenvironment, thus identifying critical factors contributing to UTUC progression and phenotypic differences between UTUC and BLCA.
scRNA-seq analysis revealed seemingly similar but transcriptionally distinct cellular identities within the UTUC and BLCA ecosystems. Notably, we observed striking differences in acquired immunological landscapes and varied cellular functional phenotypes between these two cancers. In addition, we uncovered the immunomodulatory functions of vein endothelial cells (ECs) in UTUC, and intercellular network analysis demonstrated that fibroblasts play important roles in the microenvironment. Further intersection analysis showed that MARCKS promote UTUC progression, and immunohistochemistry (IHC) staining revealed that the diverse expression patterns of MARCKS in UTUC, BLCA and normal ureter tissues.
This study expands our multidimensional understanding of the similarities and distinctions between UTUC and BLCA. Our findings lay the foundation for further investigations to develop diagnostic and therapeutic targets for UTUC.
上尿路尿路上皮癌(UTUC)和膀胱尿路上皮癌(BLCA)均起源于尿路上皮组织,具有非常相似的临床表现和治疗方式。然而,新出现的证据表明,相同的治疗方案可能导致 UTUC 的预后不如 BLCA 好。因此,探索 UTUC 的分子过程并确定 UTUC 和 BLCA 之间的生物学差异至关重要。
在这项研究中,我们对三个 UTUC 病例和四个正常输尿管组织进行了单细胞 RNA 测序(scRNA-seq)的全面分析。这些数据与之前 BLCA 研究的公开数据集和两种癌症类型的 RNA 测序(RNA-seq)数据相结合。这种综合分析使我们能够描绘微环境中不同细胞亚群的转录差异,从而确定促进 UTUC 进展的关键因素和 UTUC 与 BLCA 之间的表型差异。
scRNA-seq 分析显示,UTUC 和 BLCA 生态系统中的细胞身份似乎相似,但转录上存在明显差异。值得注意的是,我们观察到这两种癌症在获得性免疫景观和细胞功能表型方面存在显著差异。此外,我们揭示了 UTUC 中静脉内皮细胞(EC)的免疫调节功能,细胞间网络分析表明成纤维细胞在微环境中发挥重要作用。进一步的交集分析表明,MARCKS 促进 UTUC 的进展,免疫组织化学(IHC)染色显示 MARCKS 在 UTUC、BLCA 和正常输尿管组织中的表达模式存在差异。
这项研究扩展了我们对 UTUC 和 BLCA 之间相似性和差异的多维理解。我们的发现为进一步研究开发 UTUC 的诊断和治疗靶点奠定了基础。